Breaking News
March 24, 2018 - Foil-based measuring chip rapidly detects Legionella
March 24, 2018 - Bariatric surgery linked to positive outcomes in very obese adolescents with type 2 diabetes
March 24, 2018 - Are there risks from secondhand marijuana smoke? Early science says yes.
March 24, 2018 - Researchers examine link between knee pain and depression in older adults
March 24, 2018 - FDA Alert: BD Vacutainer Blood Collection Tubes by Becton, Dickinson and Company (BD): Class I Recall
March 24, 2018 - Daytime Sleepiness Linked to Amyloid Accumulation Without Dementia
March 24, 2018 - Energy storehouses in the brain may be source of Alzheimer’s, targets of new therapy
March 24, 2018 - Praising people with autism shows promise for producing more exercise
March 24, 2018 - Using harmless red or infrared light to diagnose breast cancer
March 24, 2018 - Clash over abortion hobbles a health bill. Again. Here’s how.
March 23, 2018 - Virtual nature environment could be new way to recover from stress
March 23, 2018 - New study identifies key cellular mechanisms behind vascular aging in mice
March 23, 2018 - Nightmares Common Among U.S. Troops, But Seldom Reported
March 23, 2018 - Another Record Low for Tuberculosis in U.S.
March 23, 2018 - Changes in the eye connected to a decline in memory
March 23, 2018 - Radiologist creates dramatic teaching tool using power of VR
March 23, 2018 - Grilled meat could be raising the risk of hypertension finds study
March 23, 2018 - Mutations found in bassoon gene may help explain cause of rare brain disorder
March 23, 2018 - Childhood Brain Injuries May be Linked to ADHD Years Later
March 23, 2018 - Why treating addiction with medication should be carefully considered
March 23, 2018 - Researchers make key discovery about cellular pathway linked to myriad of diseases
March 23, 2018 - Researchers uncover cause of rare childhood neurodegenerative disease
March 23, 2018 - Measles infection in early childhood could contribute to later COPD
March 23, 2018 - Opioid painkiller is top prescription in 11 states
March 23, 2018 - Sienna Biopharmaceuticals Announces First Patient Dosed In Proof-of-Concept Trial of Topical By Design™ JAK Inhibitor SNA-125 for Atopic Dermatitis
March 23, 2018 - In Teen Girls, Neural Patterns May Drive Emotional Resilience
March 23, 2018 - Gene-based test for urine detects, monitors bladder cancer
March 23, 2018 - BD to introduce new digital solution for IV chemotherapy administration process at EAHP 2018
March 23, 2018 - New computational method helps to identify tumor cell mutations with greater accuracy
March 23, 2018 - Researchers identify potential obesity treatment in freezing hunger-signaling nerve
March 23, 2018 - Wales participates in the 100,000 Genomes Project
March 23, 2018 - 24-Hr Paging Cuts ED Visits for Kids with Endocrine Issues
March 23, 2018 - The brain learns completely differently than we’ve assumed since the 20th century
March 23, 2018 - Less nutritious diet mainly contributes to Type 2 diabetes among U.S.-based South Asians
March 23, 2018 - Stony Brook Medicine expert provides tips for healthy diet to decrease cancer risk
March 23, 2018 - New findings could have revolutionary impact on quality of life of older people
March 23, 2018 - Restoring enzyme may help reverse effects of vascular aging, study shows
March 23, 2018 - Protein profiling reveals new prostate cancer mechanisms
March 23, 2018 - Depression may be linked to increased risk of atrial fibrillation
March 23, 2018 - FDA Takes Aim at Flavored Tobacco
March 23, 2018 - SMART Strategy Lowers Asthma Exacerbation Risk
March 23, 2018 - Cold open water plunge provides instant pain relief
March 23, 2018 - Portable and wearable technology supports future of military medical devices
March 23, 2018 - Patients with vascular malformations have poor health-related quality of life
March 23, 2018 - Researchers develop unique technology to overcome global antibiotic resistance crisis
March 23, 2018 - New DOD grant to support testing of promising therapy for triple-negative breast cancer
March 23, 2018 - Novel vaccine technologies can help better prepare for future infectious disease threats
March 23, 2018 - OncoBreak: Colonoscopy TV; Coverage for Genomic Testing; Care for Caregivers
March 23, 2018 - For some surgeries, nerve blocks mean better outcomes, fewer opioids
March 23, 2018 - Maternal obesity and androgen excess induce sex-specific anxiety in offspring, study suggests
March 23, 2018 - The tale of Theranos and the mysterious fire alarm
March 23, 2018 - USC researchers create algorithm to optimize substance abuse intervention groups
March 23, 2018 - Impulsivity may be associated with greater weight loss during treatment in obese children
March 23, 2018 - CTI BioPharma Announces Publication of Pacritinib Phase 3 PERSIST-2 Clinical Trial in JAMA Oncology
March 23, 2018 - Senate Panel Addresses Native Americans’ Opioid Troubles
March 23, 2018 - Brain connections in schizophrenia
March 23, 2018 - Mental health assessment in health checks can help detect psychologically vulnerable people
March 23, 2018 - New test for urothelial cancers offers less invasive, more accurate detection
March 23, 2018 - Groundbreaking 100,000 Genomes Project achieves important milestone to transform NHS care
March 23, 2018 - Mice getting a new lease of life with anti-aging pills
March 23, 2018 - Obesity kills taste buds and dulls taste sensation finds study
March 23, 2018 - Medical students get less formal education in radiation oncology, study finds
March 23, 2018 - Researchers find investigational compound to treat triple negative breast cancer after brain metastasis
March 23, 2018 - Researchers develop wearable system to monitor electrical activity in the stomach over 24 hours
March 23, 2018 - A Different Opioid Crisis | Medpage Today
March 23, 2018 - PTSD an ongoing fight for generation of Iraq War vets
March 23, 2018 - Researchers uncover specific gene region in hypertension
March 23, 2018 - Specific immune cells may help slow progression of ALS, research shows
March 23, 2018 - Biosense Webster launches new ‘Power to Heal’ campaign to alleviate AF burden
March 23, 2018 - FDA could curb or ban tobacco in menthol or fruit flavoured cigarettes soon
March 23, 2018 - Mom’s Pre-Pregnancy Waist Size Tied to Autism Risk
March 23, 2018 - AMD Treat-and-Extend Regimens OK: Ophthalmology Times
March 23, 2018 - Safe-sleep recommendations for infants have not reduced sudden deaths in newborns
March 23, 2018 - Survey finds inappropriate prescribing of antibiotics for hospitalized children
March 23, 2018 - Researchers propose alternative treatment to target lymphoma signaling at its root
March 22, 2018 - Compound found in beet extract could help slow progression of Alzheimer’s disease
March 22, 2018 - Lower temperatures can trigger the body’s ‘good’ fat formation at cellular level
March 22, 2018 - Sentinel lymph node biopsies could be safely avoided for some breast cancer patients
March 22, 2018 - Combined Preeclampsia Test Superior to U.K. Standards
March 22, 2018 - Exclusive breastfeeding in hospital associated with longer breastfeeding duration
Dear drug using up Medicare expenditures with out proof of better efficacy

Dear drug using up Medicare expenditures with out proof of better efficacy

image_pdfDownload PDFimage_print

Medicare spent greater than $1 billion over a five-year duration on a high-priced drug that has no longer been confirmed more practical for a number of inflammatory prerequisites than a lot more economical corticosteroids, analysis by means of the OHSU/OSU School of Pharmacy presentations.

The research additionally signifies relatively small staff of “common prescribers” mix to put in writing prescriptions that result in the majority of Medicare’s expenditures at the drug, repository adrenocorticotropin, or ACTH.

In 2015 on my own, Medicare spending crowned $500 million at the drug, the price of which has soared to $36,000 in line with process treatment.

Recognized by means of the industry identify H.P. Acthar Gel, steadily shortened to simply Acthar, the drug’s number one use is to regard uncommon epileptic spasms in kids beneath age 2.

“The drug has an enchanting again tale,” stated Dan Hartung, lead creator on a analysis letter that used to be revealed as of late in JAMA Inside Medication. “It is a rather outdated drug, first authorized in 1952, previous to most of the FDA laws about scientific efficacy. The bar for what constitutes authorized indications used to be a lot other then, a lot decrease; it has many indications that got here ahead of the present laws have been set in stone within the 1960s.”

The drug, categorized as a “biologic,” used to be to start with authorized for a huge vary of corticosteroid-responsive inflammatory prerequisites.

“It is a hormone produced within the human frame that alerts the discharge of steroids,” Hartung stated. “It does the similar activity as cheap corticosteroids. And it in point of fact wasn’t a lot on somebody’s radar till 2007.”

Questcor Prescribed drugs bought the rights to the in large part forgotten Acthar in 2001 for $100,000 and started often elevating Acthar’s value. In 2007 Questcor greater the cost of the drug, which as soon as bought for $40 for a vial, or process treatment, from $1,650 to $23,000 in a single day.

Questcor, got by means of Mallinckrodt Prescribed drugs in 2017, markets the drug aggressively for slightly not unusual prerequisites comparable to rheumatoid arthritis, a couple of sclerosis and nephrotic syndrome, Hartung stated. The Meals and Drug Management authorized Acthar for the ones sorts of prerequisites a long time in the past when necessities have been much less strict; no scientific trials have been required.

“There are a selection of FDA-approved indications that lack numerous proof that Acthar is even efficient, let on my own higher than reasonably priced corticosteroids,” Hartung stated. “And what lets in for this sort of pricing is that it is a rather complicated molecule and no competition can precisely replica it; they have got a monopoly in this specific molecule.”

In 2015, Acthar generated gross earnings of about $1 billion – greater than part of which got here from Medicare, and far of the remainder coming from Medicaid, Hartung stated, which means public expenditures most probably accounted for just about all the gross sales.

Hartung and the opposite collaborators discovered Medicare spending at the drug greater tenfold and totaled $1.three billion from 2011 to 2015.

In 2014, a complete of one,621 prescribers have been liable for $391.2 million in Acthar spending; amongst the ones, 203 common prescribers – 94 rheumatologists, 55 neurologists and 54 nephrologists, each and every with greater than 10 prescriptions – accounted for $165 million of the entire.

“And on the whole those physicians are prescribing about the similar collection of different medicine in comparison to their peer uniqueness teams, so we suspect they aren’t treating extra significantly unwell sufferers,” Hartung stated. “Mallinckrodt is in point of fact aggressively advertising and marketing in ways in which perhaps topic prescribers to conflicts of pastime. From the payer facet, there may be in point of fact little that little justifies this drug and its exorbitant price over a lot inexpensive choices. If Medicare have been to take a company stand on reimbursements, this would not be going down.”

Discover additional:
Mallinckrodt purchasing Questcor for approximately $five.6B (Replace)

Additional information:
JAMA Inside Medication (2017). DOI: 10.11001/jamainternmed.2017.3631

Magazine reference:
JAMA Inside Medication

Equipped by means of:
Oregon State College

Tagged with:

About author

Related Articles